As of 2025-07-20, the Fair Value of Renovaro Biosciences Inc (RENB) is -1.95 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.32 USD, the upside of Renovaro Biosciences Inc is -716.70%.
With the market price of 0.32 USD and our fair value calculation, Renovaro Biosciences Inc (RENB) is not a good investment. Investing in RENB stocks now will result in a potential loss of 716.70%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 5Y Avg | |
| Net income | -11.42 | -26.72 | -113.43 | -39.68 | -81.00 | -54.45 |
| YoY growth | 36.63% | -133.98% | -324.51% | 65.02% | -104.13% | -92.20% |
| Market Cap (mil) | 54.54 |
| P/E | |
| Forward P/E |
| EPS | -0.39 |
| Avg earnings growth rate | -92.20% |
| TTM earnings | -67.28 |